Pancreatic Cancer Research

ResearcherHarvard UniversityActive in the last 2 years

Paige M. Bracci

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0001-9338-9307; OpenAlex author ID A5053290541. Sources: ClinicalTrials.gov.

Their work

Papers
59 (first author 1, last author 8)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
1
Collaborators
109
Papers, trials and grants by year

2011: 6 papers · 2012: 8 papers · 2013: 5 papers · 2014: 5 papers · 2015: 8 papers · 2016: 3 papers · 2017: 2 papers · 2018: 2 papers · 2019: 2 papers, 1 trial · 2020: 7 papers · 2021: 4 papers · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper · 2026: 3 papers

Papers 50 of 59

  1. Polygenic scores for risk of pancreatic ductal adenocarcinoma: evaluation of novel and published models. Co-author DOI 10.1038/s41698-026-01479-x↗
  2. Different diabetes types and pancreatic ductal adenocarcinoma: a Mendelian randomization and pathway/gene-set analysis. Co-author DOI 10.1093/jnci/djaf308↗
  3. Novel Genetic Risk Loci for Pancreatic Ductal Adenocarcinoma Identified in a Genome-wide Study of African Ancestry Individuals Co-author DOI 10.64898/2026.04.21.26351329↗
  4. Allelic effects on KLHL17 expression underlie a pancreatic cancer genome-wide association signal at chr1p36.33. Co-author DOI 10.1038/s41467-025-59109-2↗
  5. Genome-Wide Analysis to Assess if Heavy Alcohol Consumption Modifies the Association between SNPs and Pancreatic Cancer Risk. Co-author DOI 10.1158/1055-9965.epi-24-0096↗
  6. Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization. Co-author DOI 10.1158/1055-9965.epi-23-0453↗
  7. The age-dependent association of risk factors with pancreatic cancer. Co-author DOI 10.1016/j.annonc.2022.03.276↗
  8. A 584 bp deletion in CTRB2 inhibits chymotrypsin B2 activity and secretion and confers risk of pancreatic cancer. Co-author DOI 10.1016/j.ajhg.2021.09.002↗
  9. Hepcidin-regulating iron metabolism genes and pancreatic ductal adenocarcinoma: a pathway analysis of genome-wide association studies. Co-author DOI 10.1093/ajcn/nqab217↗
  10. Smoking Modifies Pancreatic Cancer Risk Loci on 2q21.3. Co-author DOI 10.1158/0008-5472.can-20-3267↗
  11. A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer. Co-author DOI 10.1186/s13073-020-00816-4↗
  12. Incorporating multiple sets of eQTL weights into gene-by-environment interaction analysis identifies novel susceptibility loci for pancreatic cancer. Co-author DOI 10.1002/gepi.22348↗
  13. Abdominal Imaging of Pancreatic Cysts and Cyst-Associated Pancreatic Cancer in BRCA1/2 Mutation Carriers: A Retrospective Cross-Sectional Study. Co-author DOI 10.1016/j.jamcollsurg.2019.09.019↗
  14. A Transcriptome-Wide Association Study Identifies Novel Candidate Susceptibility Genes for Pancreatic Cancer. Co-author DOI 10.1093/jnci/djz246↗
  15. Genome-Wide Association Study Data Reveal Genetic Susceptibility to Chronic Inflammatory Intestinal Diseases and Pancreatic Ductal Adenocarcinoma Risk. Co-author DOI 10.1158/0008-5472.can-20-0447↗
  16. Associations between Genetically Predicted Blood Protein Biomarkers and Pancreatic Cancer Risk. Co-author DOI 10.1158/1055-9965.epi-20-0091↗
  17. Genome-Wide Gene-Diabetes and Gene-Obesity Interaction Scan in 8,255 Cases and 11,900 Controls from PanScan and PanC4 Consortia. Co-author DOI 10.1158/1055-9965.epi-20-0275↗
  18. Mendelian Randomization Analysis of n-6 Polyunsaturated Fatty Acid Levels and Pancreatic Cancer Risk. Co-author DOI 10.1158/1055-9965.epi-20-0651↗
  19. Agnostic Pathway/Gene Set Analysis of Genome-Wide Association Data Identifies Associations for Pancreatic Cancer. Co-author DOI 10.1093/jnci/djy155↗
  20. Analysis of Heritability and Genetic Architecture of Pancreatic Cancer: A PanC4 Study. Co-author DOI 10.1158/1055-9965.epi-18-1235↗
  21. Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer. Co-author DOI 10.1038/s41467-018-02942-5↗
  22. Pancreatic cancer risk is modulated by inflammatory potential of diet and ABO genotype: a consortia-based evaluation and replication study. Co-author DOI 10.1093/carcin/bgy072↗
  23. Dietary acrylamide and the risk of pancreatic cancer in the International Pancreatic Cancer Case-Control Consortium (PanC4). Co-author DOI 10.1093/annonc/mdw618↗
  24. Oral Health and the Oral Microbiome in Pancreatic Cancer: An Overview of Epidemiological Studies. Co-author DOI 10.1097/ppo.0000000000000287↗
  25. Risk Factors for Early-Onset and Very-Early-Onset Pancreatic Adenocarcinoma: A Pancreatic Cancer Case-Control Consortium (PanC4) Analysis. Co-author DOI 10.1097/mpa.0000000000000392↗
  26. Menstrual and Reproductive Factors, Hormone Use, and Risk of Pancreatic Cancer: Analysis From the International Pancreatic Cancer Case-Control Consortium (PanC… Co-author DOI 10.1097/mpa.0000000000000635↗
  27. Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21. Co-author DOI 10.18632/oncotarget.11041↗
  28. Statin use and risk of pancreatic cancer: results from a large, clinic-based case-control study. Last author DOI 10.1002/cncr.29256↗
  29. Metformin use among type 2 diabetics and risk of pancreatic cancer in a clinic-based case-control study. Last author DOI 10.1002/ijc.29120↗
  30. TERT gene harbors multiple variants associated with pancreatic cancer susceptibility. Co-author DOI 10.1002/ijc.29590↗
  31. Cigarette smoking and risk of pancreatic cancer: a clinic-based case-control study in the San Francisco Bay Area. Last author DOI 10.1016/j.annepidem.2015.08.011↗
  32. Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer. Co-author DOI 10.1038/ng.3341↗
  33. Vitamin D and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Case-Control Consortium. Co-author DOI 10.1093/annonc/mdv236↗
  34. Vitamin D metabolic pathway genes and pancreatic cancer risk. Co-author DOI 10.1371/journal.pone.0117574↗
  35. Correction: vitamin d metabolic pathway genes and pancreatic cancer risk. Co-author DOI 10.1371/journal.pone.0129983↗
  36. Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer. Co-author DOI 10.1038/ng.3052↗
  37. Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium. Co-author DOI 10.1093/annonc/mdu276↗
  38. Axonal guidance signaling pathway interacting with smoking in modifying the risk of pancreatic cancer: a gene- and pathway-based interaction analysis of GWAS d… Co-author DOI 10.1093/carcin/bgu010↗
  39. Genes-environment interactions in obesity- and diabetes-associated pancreatic cancer: a GWAS data analysis. Co-author DOI 10.1158/1055-9965.epi-13-0437-t↗
  40. Serum immunoglobulin e and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Co-author DOI 10.1158/1055-9965.epi-13-1359↗
  41. Polymorphisms in genes related to one-carbon metabolism are not related to pancreatic cancer in PanScan and PanC4. Co-author DOI 10.1007/s10552-012-0138-0↗
  42. Dietary patterns and risk of pancreatic cancer in a large population-based case-control study in the San Francisco Bay Area. Last author DOI 10.1080/01635581.2012.725502↗
  43. Allergies and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Case-Control Consortium. Co-author DOI 10.1093/aje/kwt052↗
  44. Ulcer, gastric surgery and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium (PanC4). Co-author DOI 10.1093/annonc/mdt336↗
  45. An absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general population. Co-author DOI 10.1371/journal.pone.0072311↗
  46. Serum autoantibodies to pancreatic cancer antigens as biomarkers of pancreatic cancer in a San Francisco Bay Area case-control study. Co-author DOI 10.1002/cncr.27538↗
  47. Obesity and pancreatic cancer: overview of epidemiologic evidence and biologic mechanisms. Co-author DOI 10.1002/mc.20778↗
  48. Obesity and survival in population-based patients with pancreatic cancer in the San Francisco Bay Area. Last author DOI 10.1007/s10552-012-0070-3↗
  49. Alcohol consumption and pancreatic cancer: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Co-author DOI 10.1093/annonc/mdr120↗
  50. Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4). Co-author DOI 10.1093/annonc/mdr541↗

Trials 1

  1. UCSF PANC Cyst Registry Principal investigator NCT04291651↗

Closest collaborators

The 25 strongest of 109 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Harvey A. Risch · 15 shared papers, 2011–2022 · strength 0.67
  2. Steve Gallinger · 16 shared papers, 2011–2022 · strength 0.65
  3. Gloria M. Petersen · 15 shared papers, 2011–2022 · strength 0.59
  4. Eric J. Duell · 15 shared papers, 2011–2020 · strength 0.55
  5. Donghui Li · 8 shared papers, 2011–2020 · strength 0.43
  6. Kimberly Saunders Kirkwood · 1 shared paper, 1 shared trial, 2019–2020 · strength 0.42
  7. Rachel Ε. Neale · 8 shared papers, 2013–2020 · strength 0.42
  8. Carlo La Vecchia · 13 shared papers, 2011–2018 · strength 0.41
  9. Robert C. Kurtz · 11 shared papers, 2011–2020 · strength 0.39
  10. Herbert Yu · 10 shared papers, 2011–2020 · strength 0.37
  11. Sara H. Olson · 12 shared papers, 2011–2019 · strength 0.37
  12. H. Bas Bueno-de-Mesquita · 13 shared papers, 2011–2016 · strength 0.37
  13. Cristina Bosetti · 10 shared papers, 2011–2018 · strength 0.32
  14. Elizabeth T. H. Fontham · 10 shared papers, 2011–2017 · strength 0.28
  15. Rachael Z. Stolzenberg‐Solomon · 4 shared papers, 2014–2022 · strength 0.26
  16. Patrick Maisonneuve · 10 shared papers, 2011–2016 · strength 0.26
  17. Jerry Polesel · 9 shared papers, 2011–2018 · strength 0.26
  18. Ghislaine Scélo · 4 shared papers, 2014–2020 · strength 0.25
  19. Alison P. Klein · 3 shared papers, 2019–2022 · strength 0.24
  20. Ersilia Lucenteforte · 9 shared papers, 2011–2017 · strength 0.23
  21. Debra T. Silverman · 9 shared papers, 2011–2014 · strength 0.22
  22. Roger Laughlin Milne · 3 shared papers, 2018–2022 · strength 0.22
  23. Wei Zheng · 3 shared papers, 2018–2022 · strength 0.22
  24. Xiao‐Ou Shu · 3 shared papers, 2018–2022 · strength 0.22
  25. Dali Li · 8 shared papers, 2011–2017 · strength 0.21

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.